Mercer Global Advisors
TXG icon

Mercer Global Advisors’s 10x Genomics TXG Stock Holding History

Mercer Global Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Sell
108,692
-6,280
-5% -$165K 0.01% 962
2026
Q1 		$2.44M Buy
114,972
+31,706
+38% +$634K ﹤0.01% 1095
2025
Q4 		$1.36M Buy
83,266
+36,938
+80% +$558K ﹤0.01% 1304
2025
Q3 		$542K Buy
46,328
+22,282
+93% +$291K ﹤0.01% 1720
2025
Q2 		$278K Buy
+24,046
New +$219K ﹤0.01% 1886

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's TXG Position: Q2 2026 in Review

Mercer Global Advisors reduced its 10x Genomics (TXG) stake by 5.5% in Q2 2026, selling an estimated $165K and leaving 108,692 shares worth $4.17M. The position accounts for 0.01% of the portfolio, ranked #962.

Mercer Global Advisors first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Mercer Global Advisors held 108,692 shares of 10x Genomics worth $4.17M as of Q2 2026.
  • Mercer Global Advisors sold 6,280 10x Genomics shares in Q2 2026, an estimated $165K.
  • 10x Genomics made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #962 holding.
  • Mercer Global Advisors first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.